Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro

Toxicology and Applied Pharmacology

Volumn 253, Issue 1, 2011, Pages 7-13

  Herkert, N M ^a   Schulz, S ^b   Wille, T ^a   Thiermann, H ^a   Hatz, R A ^b   Worek, F ^a  

^a BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

^b Asklepios Clinic   (Germany)

Author keywords

Acetylcholinesterase; Enzyme kinetics; Inhibition; Organophosphorus compound; Physostigmine; Soman

Indexed keywords

ACETYLCHOLINESTERASE; PHYSOSTIGMINE; SOMAN;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFICACY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME REACTOR; ERYTHROCYTE COUNT; GUINEA PIG; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTOXICATION; MUSCLE PERFUSION; NONHUMAN;

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ERYTHROCYTES; HUMANS; INTERCOSTAL MUSCLES; PHYSOSTIGMINE; SOMAN; TIME FACTORS; TREATMENT OUTCOME;

CAVIA;

EID: 79955018822     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.03.005     Document Type: Article

References (37)

1. Berry W.K., Davies D.R. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2- trimethylpropylmethylphosphonofluoridate. Biochem. Pharmacol. 1970, 19:927-934.
2. de Jong L.P.A., Wolring G.Z. Stereospecific reactivation by some Hagedorn-oximes of acetycholinesterases from various species including man inhibited by soman. Biochem. Pharmacol. 1984, 33:1119-1125.
3. Deshpande S.S., Viana G.B., Kauffman F.C., Rickett D.L., Albuquerque E.X. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning. Fundam. Appl. Toxicol. 1986, 6:566-577.
4. Dirnhuber P., French M.C., Green D.M., Leadbeater L., Stratton J.A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 1979, 31:295-299.
5. Due A.H., Trap H.C., Langenberg J.P., Benschop H.P. Toxicokinetics of soman stereoisomers after subcutaneous administration to atropinized guinea pigs. Arch. Toxicol. 1994, 68:60-63.
6. Eckert S., Eyer P., Herkert N., Bumm R., Weber G., Thiermann H., Worek F. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin and paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity. Biochem. Pharmacol. 2008, 75:698-703.
7. Eckert S., Eyer P., Mückter H., Worek F. Development of a dynamic model for real-time determination of membrane-bound acetylcholinesterase activity upon perfusion with inhibitors and reactivators. Biochem. Pharmacol. 2006, 72:358-365.
8. Eckert S., Eyer P., Mückter H., Worek F. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Biochem. Pharmacol. 2006, 72:344-357.
9. Eckert S., Eyer P., Worek F. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge. Toxicology 2007, 233:180-186.
10. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol. Rev. 2003, 22:165-190.
11. Eyer P., Szinicz L., Thiermann H., Worek F., Zilker T. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality. Toxicology 2007, 233:108-119.
12. Eyer P., Worek F. Oximes. Chemical Warfare Agents: Toxicology and Treatment 2007, 305-329. John Wiley & Sons Ltd., Chichester. T.C. Marrs, R.L. Maynard, F.R. Sidell (Eds.).
13. Gordon J.J., Leadbeater L., Maidment M.P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 1978, 43:207-216.
14. Haigh J.R., Adler M., Apland J.P., Deshpande S.S., Barham C.B., Desmond P., Koplovitz I., Lenz D.E., Gordon R.K. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure. Chem. Biol. Interact. 2010, 187:416-420.
15. Haigh J.R., Johnston S.R., Peters B.M., Doctor B.P., Gordon R.K., Adler M., Gall K.J., Deshpande S.S. Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity. Chem. Biol. Interact. 2005, 157-158:381-382.
16. Herkert N., Eckert S., Eyer P., Bumm R., Weber G., Thiermann H., Worek F. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors. Toxicology 2008, 246:188-192.
17. Herkert N.M., Aurbek N., Eyer P., Thiermann H., Worek F. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon. Toxicol. Lett. 2010, 194:94-101.
18. Herkert N.M., Lallement G., Clarencon D., Thiermann H., Worek F. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity. Toxicology 2009, 258:79-83.
19. Hobbiger F. Reactivation of phosphorylated acetylcholinesterase. Cholinesterases and anticholinesterase agents 1963, 921-988. Springer-Verlag, Berlin. G.B. Koelle (Ed.).
20. Lennox W.J., Harris L.W., Talbot B.G., Anderson D.R. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci. 1985, 37:793-798.
21. Lukey B.J., Parrish J.H., Marlow D.D., Clark C.R., Sidell F.R. Pharmacokinetics of physostigmine intramuscularIy administered to guinea pigs. J. Pharm. Sci. 1990, 79:796-798.
22. MacIlwain C. Study proves Iraq used nerve gas. Nature 1993, 363:3.
23. Marrs T.C. Organophosphate poisoning. Pharmacol. Ther. 1993, 58:51-66.
24. Marrs T.C., Maynard R.L., Sidell F.R. Opinions of chemical Warfare 1996, Chem. warfare.
25. Nagao M., Takatori T., Matsuda Y., Nakajima M., Iwase H., Iwadate K. Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol. Appl. Pharmacol. 1997, 144:198-203.
26. Philippens I.H.C.H.M., Busker R.W., Wolthuis O.L., Olivier B., Bruijnzel P.L.B., Melchers B.P.C. Subchronic physostigmine pretreatment in guinea pigs: effective against soman and without side effects. Pharmacol. Biochem. Behav. 1998, 59:1061-1067.
27. Philippens I.H.C.H.M., Vanwersch R.A.P., Groen B., Olivier B., Bruijnzel P.L.B., Melchers B.P.C. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation. Toxicol. Sci. 2000, 53:84-91.
28. Scott L. Pretreatment for nerve agent poisoning. Chemical Warfare Agents: Toxicology and Treatment 2007, 343-353. John Wiley & Sons Ltd., Chichester. T.C. Marrs, R.L. Maynard, F.R. Sidell (Eds.).
29. Shaw K.P., Aracava Y., Akaike A., Daly J.W., Rickett D.L., Albuquerque E.X. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agoinst effects on the acetylcholine receptor-ion channel complex. Mol. Pharmacol. 1985, 28:527-538.
30. Sket D. Efficacy of antidotes against soman poisoning in female physostigmine-protected rats. Pharmacol. Toxicol. 1993, 72:25-30.
31. Talbot B.G., Anderson D.R., Harris L.W., Yarbrough L.W., Lennox W.J. A comparison of in vivo and in vitro rates of aging of soman- inhibited erythrocyte acetylcholinesterase in different animal species. Drug Chem. Toxicol. 1988, 11:289-305.
32. Van Helden H.P.M., Busker R.W., Melchers B.P.C., Bruijnzel P.L.B. Pharmacological effects of oximes: how relevant are they?. Arch. Toxicol. 1996, 70:779-786.
33. Von Bredow J.D., Corcoran K., Maitland G., Kaminskis A., Adams N., Wade J. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication. Fundam. Appl. Toxicol. 1991, 17:782-789.
34. Wetherell J., Price M., Mumford H. A novel approach for medical countermeasures to nerve agent poisoning in the guinea-pig. Neurotoxicology 2006, 27:485-491.
35. Wetherell J., Price M., Mumford H., Armstrong S., Scott L. Development of next generation medical countermeasures to nerve agent poisoning. Toxicology 2007, 233:120-127.
36. Wetherell J.R. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J. Pharm. Pharmacol. 1994, 46:1023-1028.
37. Worek F., Mast U., Kiderlen D., Diepold C., Eyer P. Improved determination of acetylcholinesterase activity in human whole blood. Clin. Chim. Acta 1999, 288:73-90.